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Abstract
Background: We previously reported in vitro maintenance and proliferation of human small intestinal epithelium using
Matrigel, a proprietary basement membrane product. There are concerns over the applicability of Matrigel-based methods
for future human therapies. We investigated type I collagen as an alternative for the culture of human intestinal epithelial
cells.
Methods: Human small intestine was procured from fresh surgical pathology specimens. Small intestinal crypts were
isolated using EDTA chelation. Intestinal subepithelial myofibroblasts were isolated from a pediatric sample and expanded
in vitro. After suspension in Matrigel or type I collagen gel, crypts were co-cultured above a confluent layer of
myofibroblasts. Crypts were also grown in monoculture with exposure to myofibroblast conditioned media; these were
subsequently sub-cultured in vitro and expanded with a 1:2 split ratio. Cultures were assessed with light microscopy, RT-
PCR, histology, and immunohistochemistry.
Results: Collagen supported viable human epithelium in vitro for at least one month in primary culture. Sub-cultured
epithelium expanded through 12 passages over 60 days. Histologic sections revealed polarized columnar cells, with apical
brush borders and basolaterally located nuclei. Collagen-based cultures gave rise to monolayer epithelial sheets at the gel-
liquid interface, which were not observed with Matrigel. Immunohistochemical staining identified markers of differentiated
intestinal epithelium and myofibroblasts. RT-PCR demonstrated expression of a-smooth muscle actin and vimentin in
myofibroblasts and E-Cadherin, CDX2, villin 1, intestinal alkaline phosphatase, chromogranin A, lysozyme, and Lgr5 in
epithelial cells. These markers were maintained through several passages.
Conclusion: Type I collagen gel supports long-term in vitro maintenance and expansion of fully elaborated human intestinal
epithelium. Collagen-based methods yield familiar enteroid structures as well as a new pattern of sheet-like growth, and
they eliminate the need for Matrigel for in vitro human intestinal epithelial growth. Future research is required to further
develop this cell culture system for tissue engineering applications.
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Introduction
The last decade of research into the intestinal epithelial stem cell
niche has been marked by exciting new insights which have
resulted in numerous experimental systems of long-term in vitro
epithelial growth. This work has been facilitated by the
identification of critical growth factors, the use of three-dimen-
sional culture techniques that provide a near-physiologic extra-
cellular environment, and better characterization of supportive
cells within the niche [1–4]. Though these culture systems have
proven essential for advancement of in vitro research in the field,
few studies have sought to further develop their clinical
applicability. In particular, Matrigel, the most widely used
extracellular matrix in epithelial cell culture, is unlikely to make
the transition from bench to bedside as it is a poorly characterized
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mouse sarcoma digestate [5]. Furthermore, its inherent batch-to-
batch variability is a significant obstacle in planning reproducible
in vitro studies [6].
We have previously investigated type I collagen as a clinically
and scientifically relevant alternative [7]. Collagen is the most
abundant protein in animals, with twenty-eight distinct subtypes
identified to date [8]. Type I collagen, the predominant subtype, is
found mostly in connective tissue; can be easily and reproducibly
isolated; and is relatively non-immunogenic. Importantly, there
are several precedents for the use of collagen as a biomaterial in
the clinical setting [9–12]. Given these clear advantages over
existing three-dimensional culture systems, its application in
intestinal regeneration is a promising avenue to direct current
investigation.
In this investigation, we further develop three-dimensional
human small intestinal epithelial culture methodology by demon-
strating the capacity of type I collagen gel to replace Matrigel. By
synthesizing insights from the collagen-based murine small
intestinal model as well as prior techniques for human small
intestinal culture, we propose a new direction for clinically-
relevant approaches to in vitro intestinal epithelial culture.
Materials and Methods
Ethics Statement
All human tissues used in this study were obtained from
discarded surgical specimens following clinical surgical pathology
evaluation. This was approved by the UCLA Institutional Review
Board (IRB #11-002189). The IRB waived the requirement for
informed consent for tissues obtained from the UCLA Transla-
tional Pathology Core Laboratory (IRB #11-002504).
Intestinal Subepithelial Myofibroblast Isolation, Culture,
and Characterization
Intestinal subepithelial myofibroblasts (ISEMFs) were isolated
from an enterectomy performed on an infant. The jejunal sample
was washed vigorously with phosphate buffered saline (PBS)
(Fisher Scientific, Pittsburgh, PA), and the mucosa was separated
from the seromuscular layer using sharp dissection. The epithe-
lium was removed from the mucosa according to a previously
described protocol [13], and the mucosal remnant was incubated
for 3 weeks in ISEMF medium consisting of Dulbecco’s modified
Eagle medium (DMEM)/Low Glucose/GlutaMAX (Invitrogen,
Carlsbad, CA), 10% fetal bovine serum (FBS) (Invitrogen), 1x
Antibiotic-Antimycotic (Invitrogen), 0.25 units/mL insulin (Sigma,
St. Louis, MO), 20 ng/mL recombinant murine EGF (PeproTech,
Rocky Hill, NJ), and 10 mg/mL transferrin (Sigma).
After they migrated from the mucosal remnants, the ISEMF
population was sub-cultured and expanded as follows. When the
ISEMFs reached confluency, they were gently washed with sterile
PBS, treated with 1x TrypLE (Invitrogen), resuspended in ISEMF
medium, and re-plated at a concentration of 200,000 ISEMFs/
75 cm2. After iterative expansion through the first four passages in
vitro, the ISEMFs were frozen in liquid nitrogen in 10% dimethyl
sulfoxide (ATCC, Manassas, VA), 40% FBS, and 50% DMEM as
a cryoprotectant for future studies. The ISEMFs were subse-
quently characterized by immunofluorescent staining and mes-
senger RNA assessment as described below.
Small Intestinal Crypt Isolation
Human small intestinal tissue samples were procured from
pancreatico-duodenectomy, enterectomy, and ileostomy reversal
surgical pathology specimens. The seromuscular layer was sharply
dissected off of the overlying mucosa and discarded. Crypts were
isolated from the mucosa as previously described with slight
modification [4]; 8 mM ethylenediaminetetraacetate (EDTA)
(Sigma) and 1 mM dithiothreitol (DTT) (Sigma) were used for
the dissociation step, and crypts were only filtered through a
100 mm pore cell strainer (BD Biosciences, Bedford MA). Crypts
were resuspended in 5 mL of Basic Crypt Medium, consisting of
Advanced DMEM/Ham’s F12 (Invitrogen) with 2 mM Gluta-
MAX (Invitrogen), 10 mM HEPES (Invitrogen), and 1x Antibi-
otic-Antimycotic (Invitrogen). Each experiment performed repre-
sented a distinct patient sample, and specimens were not pooled.
Crypt Culture Technique
ISEMFs were pre-plated at an initial density of 25,000 cells/cm2
within 48-well Costar cell culture plates (Fisher) and allowed to
grow to confluency several days before crypt isolation. Standard
formulation Matrigel (BD Biosciences) was thawed on ice, and a
type I collagen gel (Cellmatrix type I-A porcine tendon collagen,
3 mg/mL, Nitta Gelatin Inc., Osaka, Japan) was also prepared as
previously described [7]. Crypts were counted and suspended
within Matrigel or collagen, at a concentration of 250 crypts per
25 mL of either gel; the three-dimensional suspension was then
plated over the confluent monolayer of ISEMFs. Cultures were
treated with 250 mL of Complete Crypt Medium (CCM)
consisting of Basic Crypt Medium, 1 mM N-Acetylcysteine
(Sigma), 100 ng/mL recombinant murine Noggin (PeproTech),
50 ng/mL recombinant murine EGF (PeproTech), 1x N2
supplement (Invitrogen), 1x B27 supplement (Invitrogen), 1 mg/
mL recombinant human (rh) R-spondin 1 (R&D Systems,
Minneapolis, MN), 100 ng/mL of rhWnt3A (R&D Systems),
and 100 ng/mL of rhFGF10 (Peprotech). Fresh CCM was
replaced every 4 days, and growth factors (Noggin, EGF, R-
spondin 1, Wnt3A, and FGF10) were supplemented 2 days after
each new medium delivery.
Culture growth was assessed with inverted light microscopy on a
Nikon Eclipse Ti-U (Nikon Instruments Inc., Melville, NY). A
subset of culture wells were terminated after one week in vitro by
overnight fixation with 10% buffered formalin with subsequent
histologic analysis (see below) or lysis in RNA stabilization buffer.
Intestinal Epithelial Sub-culture Technique
For intestinal epithelial sub-culturing, several experiments were
initiated with crypt monocultures in the presence of ISEMF-
conditioned media. ISEMF-conditioned Complete Crypt Medium
(IC-CCM) was prepared in the following manner. ISEMFs were
sub-cultured into a T-75 culture flask (Corning, Tewksbury, MA)
and treated with ISEMF medium. The media was removed after
one week of incubation and stored in a 4uC refrigerator for
subsequent use. IC-CCM was constituted prior to each use by
preparing a 1:1 mixture of the spent ISEMF medium with doubly-
concentrated CCM, such that the final concentration of the
specific nutrients and growth factors above was unchanged.
2.5 mM CHIR99021 (Stemgent, Cambridge, MA) and 10 mM Y-
27632 (Sigma) were also added.
Small intestinal crypts were isolated and suspended as above.
They were then plated into 48-well Nunclon Delta-treated cell
culture plates (Thermo Scientific, Waltham, MA) and treated with
IC-CCM. The resultant epithelial units were sub-cultured every
4–5 days with a 1:2 split ratio, using type XI-S collagenase (Sigma)
and gentle mechanical disruption. They were then resuspended in
collagen gel and re-plated followed by continued IC-CCM
treatment.
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Immunofluorescent Staining and Histologic Analysis
Sub-cultured ISEMFs were characterized by in situ immuno-
fluorescent staining. ISEMFs were fixed overnight in 10% buffered
formalin, following by permeabilization with 0.5% Triton-X
(Sigma) in Tris buffer solution and washing with 0.05% Tween 20
(EMD Chemicals, Philadelphia, PA) in PBS. Primary antibodies
against a-smooth muscle actin (SMA) (Dako, Carpinteria, CA),
vimentin (Abcam, Cambridge, MA), and desmin (Dako) were
incubated overnight at 4uC at a 1:50 dilution. After washing in
PBS, AlexaFluor-488 conjugated secondary antibodies (Invitrogen)
were incubated for 30 minutes at room temperature at a 1:200
dilution, and nuclei were visualized with DAPI and Vectashield
(Vector Labs, Burlingame, CA).
In vitro epithelial cultures were fixed overnight in 10% buffered
formalin and embedded in paraffin blocks. Serial 5 mm sections
were cut and prepared for either hematoxylin and eosin or
immunohistochemical staining. Immunostaining was performed
with antibodies directed against caudal type homeobox 2 (Cdx2),
E-cadherin, CD10, lysozyme, chromogranin A, and a-smooth
muscle actin. Mucin was detected using Periodic Acid-Schiff-
Green staining [7].
Polymerase Chain Reaction
Messenger RNA (mRNA) was isolated from sub-cultured
ISEMFs and intestinal epithelial cultures with the RNeasy Mini
Kit (Qiagen, Valencia, CA). Reverse transcriptase polymerase
chain reaction (RT-PCR) was performed to determine the
expression levels of genes of interest, using Taqman Gene
Expression Assays (Applied Biosystems, Carlsbad, CA) for smooth
muscle actin (ACTA2), vimentin (VIM), desmin (DES), E-
Cadherin (CDH1), caudal type homeobox 2 (CDX2), villin 1
(VIL1), intestinal alkaline phosphatase (ALPI), chromogranin A
(CHGA), lysozyme (LYZ), Lgr5 (LGR5), and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), as previously described [7].
RT-PCR reactions were performed on a Prism 7900 HT
Sequence Detection System (Applied Biosystems). Cycle numbers
were analyzed according to the comparative CT method using
GAPDH as the internal calibrator and human whole small
intestine as the reference tissue [14].
Statistical Analysis
Two-tailed paired Student’s t-test was used to compare results
from the experiments involving primary culture. Single factor
analysis of variance (ANOVA) was used to compare mRNA results
from different passages from the sub-cultured experiments.
Results
ISEMF Characterization
Sub-cultured ISEMFs appeared as elongated spindle-shaped
cells in vitro. The characteristic phenotype of weak SMA
expression, robust vimentin expression, and minimal desmin
expression was confirmed by both immunofluorescence and RT-
Figure 1. Characterization of intestinal subepithelial myofibroblast phenotype. A–C: Immunofluorescent staining against a-smooth
muscle actin (A), vimentin (B), and desmin (C). Scale bar 100 mm (100x magnification). D: Gene expression by reverse transcriptase polymerase chain
reaction. ACTA2: a-smooth muscle actin. DES: desmin. VIM: vimentin.
doi:10.1371/journal.pone.0107814.g001
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PCR (Figure 1). Thawed ISEMFs subsequently demonstrated the
same characteristic immunophenotype (data not shown).
In Vitro Intestinal Epithelial Growth in Primary Co-culture
with ISEMFs
Human small intestinal crypts suspended in collagen gel
consistently gave rise to in vitro epithelial units previously termed
‘‘enteroids’’ when grown in co-culture with ISEMFs (N= 8) [15].
Crypts plated in monoculture without IC-CCM underwent
autolysis within 2–3 days. Co-cultured enteroids on top of ISEMFs
rapidly grew over the first week after initial isolation (Figure 2).
Thereafter, their growth slowed but remained viable with sharp
basolateral borders for up to one month in primary culture
(Figure 2, final panel). Moreover, cultured human epithelium
demonstrated a tendency to form a monolayer of cells at the
collagen-media interface (Figure 3). Crypts suspended in Matrigel
similarly yielded enteroids only in the presence of ISEMF co-
culture [4]. No surface epithelial sheets were noted to arise from
Matrigel-based cultures.
Assessment of Cell Lineage Differentiation
The phenotypic differentiation of cultured epithelium was
assessed immunohistochemically as well as by RT-PCR. Colla-
gen-based cultures yielded staining patterns characteristic of
differentiated intestinal epithelial cell lineages. They stained
positively for absorptive enterocyte (Cdx2, E-Cadherin, CD10),
goblet (Periodic Acid-Schiff), and enteroendocrine (Chromogranin
A) cells; further, anti-SMA staining verified the expected
subepithelial position of the supportive ISEMFs (Figure 4). The
RT-PCR data confirmed these findings and in addition provided
evidence of Paneth cell (LYZ) differentiation (Figure 5). Chromo-
granin A demonstrated the only statistically significant difference
in mRNA expression levels between Matrigel- and collagen-based
cultures among the target genes assessed.
In Vitro Intestinal Epithelial Sub-culturing
Small intestinal crypts reproducibly grew in collagen-based
monoculture when exposed to IC-CCM (N=3). In the absence of
IC-CCM, crypts underwent autolysis in 2–3 days. Crypts grown in
IC-CCM appeared as simpler cystic structures with flatter
Figure 2. In vitro growth of human intestinal enteroids co-cultured with intestinal subepithelial myofibroblasts in collagen gel. Scale
bar 100 mm (40x magnification).
doi:10.1371/journal.pone.0107814.g002
Figure 3. Hematoxylin and eosin stained sections of human small intestinal epithelium in collagen gel. Both enteroids and monolayer
epithelial sheets are noted (A), with confluence of these two domains at areas where the enteroids have grown or migrated to the surface of the
collagen gel (B). Scale bar 100 mm (200x magnification).
doi:10.1371/journal.pone.0107814.g003
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epithelialized walls (Figure 6), when compared with crypts co-
cultured with ISEMFs (Figures 2,3). Hereafter we refer to these
structures arising from IC-CCM supported monoculture as
‘‘enterospheres.’’ Enterospheres were successfully sub-cultured
through 12 passages over the course of 60 days following initial
crypt isolation (N=1; Figure 7, panel A). Sub-cultured entero-
spheres retained the characteristic immunophenotype of intestinal
epithelium (Figure 6, panels C/D). In addition, they were found to
contain Chromogranin A and Lysozyme positive cells. RT-PCR
demonstrated sustained expression of intestinal epithelial markers
across several passages (Figure 8). On one occasion, passaged
enterospheres appeared to have fused to form a very large enteroid
(Figure 7, panel B), measuring approximately 2 mm by 1 mm in
optical cross-section.
Discussion
In this study, we have demonstrated that type I collagen can
serve as a well-defined extra-cellular matrix for the reproducible in
vitro growth of human small intestinal epithelium derived from
healthy small intestinal crypts. The resultant cultures were shown
to fully elaborate all major intestinal epithelial lineages. Enteroids
co-cultured with ISEMFs were stable in collagen-based culture for
one month in primary culture. Small intestinal enterospheres were
successfully sub-cultured through 12 passages in the presence of
Figure 4. Immunohistochemical evidence of intestinal epithelial cell lineage differentiation in collagen. A: Cdx2 (caudal type
homeobox 2). B: E-Cadherin. C: CD10. D: Periodic Acid-Schiff. E: Chromogranin A. F: a-smooth muscle actin. Scale bar 100 mm (200x magnification).
doi:10.1371/journal.pone.0107814.g004
Figure 5. Gene expression profile of enteroids co-cultured with intestinal subepithelial myofibroblasts, relative to native small
intestine, on a logarithmic scale. Reverse transcriptase polymerase chain reaction was performed on mRNA isolated from co-cultures after 1 week
in vitro, using GAPDH as an internal calibrator gene. N= 7 for Matrigel, and N=6 for collagen. Error bars denote standard deviation, and p-values are
reported for Student’s t-test comparing individual genes. CDH1: E-Cadherin. CDX2: caudal type homeobox 2. VIL1: villin 1. ALPI: intestinal alkaline
phosphatase. CHGA: chromogranin A. LYZ: lysozyme. LGR5: leucine-rich repeat-containing G-protein coupled receptor 5.
doi:10.1371/journal.pone.0107814.g005
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ISEMF-conditioned medium. This work builds upon and high-
lights the key role that ISEMFs play in the in vitro intestinal
epithelial stem cell niche [4,16,17].
The rapid proliferation in the last 5 years of experimental
models for long-term in vitro gastrointestinal epithelial cell culture
is a testament to an increasingly nuanced understanding of the
intestinal stem cell niche, including its cellular players and cell-
signaling mediators [18]. Since Sato’s original description of long-
term murine small intestinal epithelial culture [2], various reports
have clarified the details necessary to culture the primary epithelia
of human normal small intestine; normal and dysplastic colon; and
metaplastic esophagus [4,19,20]. These studies have all employed
Matrigel as an extracellular matrix for three-dimensional cell
suspension. While its prolific application in mammalian cell
culture spans over 2 decades [21], Matrigel ultimately remains a
poorly defined and variable xenobiotic product derived from
mouse sarcoma, with potential sterility concerns [5,6,22]. As such,
the body of published work to date falls short of an ideal
experimental model poised for translation into the clinic. These
considerations have motivated efforts to supplant the use of
Matrigel in other domains of stem cell research [23].
Similarly motivated by the goal of clinically translatable
technology founded in good manufacturing practices, we and
others have reported collagen-based culture systems for murine
small intestinal epithelium [7,24]. Matrigel-free systems have also
been described for culturing immortalized human colorectal
adenocarcinoma lines in vitro [25–28]. A recent report describes
the in vivo generation of human small intestinal tissue derived
from organoid units using biocompatible polymeric scaffolds and
type I collagen gel coating [29]. However, this approach relies on
the isolation of less cytologically pure stem cell-containing units; it
also currently has the vexing disadvantage of requiring large
amounts of starting material to generate relatively modest amount
of tissue engineered small intestine.
To our knowledge, our system is unique as a biochemically- as
well as cytologically-defined approach to the in vitro expansion
and maintenance of non-transformed human small intestinal
epithelium. This collagen-based system is advantageous for these
reasons as well as for its capacity to expand a small amount of
starting material in vitro, an important facet of intestinal tissue
engineering paradigms. The Cellmatrix collagen product em-
ployed in this investigation has not yet been rigorously scrutinized
as produced via good manufacturing practices. The future
challenges notwithstanding, we anticipate its validation to be far
less problematic than pursuing approval of Matrigel for clinical
use, given the existing precendents of porcine collagen products
already in clinical use [11,30]. In contrast with Matrigel’s well-
described batch-to-batch variability [6], type I collagen has
produced consistent results in our hands. This too will remain to
be validated in a dedicated study in the future.
We are nonetheless faced with certain limitations to our current
approach. Our system affords the capacity for long-term in vitro
intestinal epithelial maintenance, but its support of enteroids or
enterospheres in vivo has yet to be demonstrated. This will remain
a critical task on the horizon. While the growth factor cocktail
described by Sato and colleagues remains a cornerstone of recent
progress in the field, we ultimately hope to achieve a fully
autonomous system that recapitulates the intestinal stem cell niche
in vitro. Early evidence utilizing ISEMFs suggests that our system
may have the capacity to obviate the need for exogenous provision
of growth factors, but further research is presently required to
develop this potential. This observation of course begs the question
of the mechanism of myofibroblast support of the intestinal stem
cell niche, which we have not sought to further characterize in this
study; this remains an area of active investigation [31].
In this investigation, we observed a new phenotype unique to
the collagen-based system, the early appearance of an epithelial
monolayer at the gel-liquid interface. Similar to prior experience
in the murine model [7], epithelial sheets were ubiquitously seen in
Figure 6. In vitro growth of human intestinal epithelium in monoculture with exposure to myofibroblast conditioned medium. A:
Monocultured enterospheres appear as simpler, thinner-walled cysts. B: Hematoxylin and eosin-stained cross-section of an enterosphere. C: Cdx2
staining. D: E-Cadherin staining. Scale bar 100 mm (A: 40x magnification; B–D: 200x magnification).
doi:10.1371/journal.pone.0107814.g006
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association with enteroids which had grown near the surface of the
collagen (Figure 3). It is conceivable that this is merely a
consequence of the natural behavior of polarized, basement
membrane-anchored cells when geometric boundary conditions
are imposed. However, it remains unclear why epithelial
monolayers are observed in collagen-based cultures and yet are
rare and late events when enteroids are grown in Matrigel. Despite
the novel morphology of collagen-based cultures, the gene
expression profiles of intestinal epithelium grown in Matrigel
versus type I collagen gel were relatively similar (Figure 5). This
may reflect a relative insensitivity of the selected target genes to
characterize the obvious morphologic differences; whole tran-
scriptome sequencing methods hold promise to better characterize
the differences between the Matrigel and collagen phenotypes. In
particular, we did observe a relatively low expression of intestinal
alkaline phosphatase in both Matrigel- and collagen-based cultures
(Figure 5); we attribute this to the ‘‘crypt-like’’ phenotype
promoted by growth factor cocktail. The ability of gut epithelium
to generate intestinal alkalkine phosphatase will be important in
providing in vivo innate immunity [32,33]. Our laboratory is
performing ongoing experiments to induce further ‘‘villous-like’’
differentiation including up-regulation of this particular gene.
Further research should involve reconstitution of the other
extracellular matrix constituents of Matrigel, as well as experi-
mental manipulation of the collagen gel biomechanical properties
[34]. The ability to leverage control over the specific intended
morphology will be in an important tool in the future of intestinal
tissue engineering. Ultimately, the capacity to grow organized
epithelial sheets may aid in transitioning from micro-scale cultures
to macro-scale neomucosa. The ability to promote formation of
fused enteroid superstructures may also figure in future solutions to
this challenge. This was an isolated and unexpected finding of our
passaging methodology, and it will need to be validated and
studied more extensively in the future.
The unique facets of collagen-based intestinal epithelial culture
hold promise for future efforts in intestinal tissue engineering.
Future effort will need to be directed towards understanding the
mechanistic underpinning of the extracellular matrix-dependent
Figure 7. A: Sub-culturing of monocultured enterospheres with exposure to myofibroblast conditioned medium. ‘P’ denotes passage
number; passages 8–10 are omitted for brevity. B: Large enteroid formed by fusion of passaged enterospheres. Scale bar 100 mm (40x magnification).
doi:10.1371/journal.pone.0107814.g007
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phenomena described herein. Further development of this fully
defined culture system will be important in supporting clinically-
translatable technologies in the future.
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